Literature DB >> 2253555

The MPTP story: MAO activates tetrahydropyridine derivatives to toxins causing parkinsonism.

G Maret1, B Testa, P Jenner, N el Tayar, P A Carrupt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253555     DOI: 10.3109/03602539009041087

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


× No keyword cloud information.
  5 in total

1.  Inhibition of rat brain microsomal cytochrome P450-dependent dealkylation activities by an oxidative stress.

Authors:  P Lagrange; R D El-Bachá; P Netter; A Minn
Journal:  Neurotox Res       Date:  2001-08       Impact factor: 3.911

Review 2.  The role of active metabolites in drug toxicity.

Authors:  M Pirmohamed; N R Kitteringham; B K Park
Journal:  Drug Saf       Date:  1994-08       Impact factor: 5.606

3.  Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases.

Authors:  Ana López; Francisco Ortiz; Carolina Doerrier; Carmen Venegas; Marisol Fernández-Ortiz; Paula Aranda; María E Díaz-Casado; Beatriz Fernández-Gil; Eliana Barriocanal-Casado; Germaine Escames; Luis C López; Darío Acuña-Castroviejo
Journal:  PLoS One       Date:  2017-08-11       Impact factor: 3.240

4.  The Effect of Neurotoxin MPTP and Neuroprotector Isatin on the Profile of Ubiquitinated Brain Mitochondrial Proteins.

Authors:  Olga Buneeva; Arthur Kopylov; Inga Kapitsa; Elena Ivanova; Victor Zgoda; Alexei Medvedev
Journal:  Cells       Date:  2018-07-31       Impact factor: 6.600

Review 5.  Mitochondrial Dysfunction in Parkinson's Disease: Focus on Mitochondrial DNA.

Authors:  Olga Buneeva; Valerii Fedchenko; Arthur Kopylov; Alexei Medvedev
Journal:  Biomedicines       Date:  2020-12-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.